Generation Lab

About Generation Lab

Generation Lab focuses on slowing aging and preventing disease through the world's most accurate epigenetic test, the SystemAge™ Test. Their mission is to provide personalized insights and precise data to optimize aging at the organ level, using 460 biomarkers across 19 organs and systems.

Products & Services

SystemAge™ Test:An at-home epigenetic test that measures biological age with 460 biomarkers across 19 systems, providing personalized insights, health risk detection, and action plans to slow aging.

Specialties

Epigenetics Biological Age Testing Personalized Health Insights Longevity Medicine Preventive Healthcare

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Seed T: - FT: Seed	A: 11000000 MR: - FA: $11 million FAN: 11000000	D: 2025-10-23 FD: 2025-10-23	6 investors

Seed Latest

2025-10-23

$11.0M

6 investors (Pro only)

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

G

George Church

The Robert Winthrop Professor of Genetics at Harvard Medical School

A

Adeel Khan

Regenerative Medicine Doctor

A

Aubrey de Grey

Biomedical Gerontologist

I

Irina Conboy

Co-Founder & CSO

A

Alina Rui Su

Co-Founder & CEO

M

Michael Suswal

Co-Founder & COO

View 3 more team members with Pro

Unlock Full Team Directory

Recent News

Generation Lab Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised